Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
OPKO Health revenue
OPKO Health's revenue is $713.1 million.
What is OPKO Health's revenue?
- OPKO Health's revenue growth from 2002 to 2024 is 126,793.59%.
- OPKO Health has 6,096 employees, and the revenue per employee ratio is $116,985.
- OPKO Health's peak quarterly revenue was $182.2M in 2024(q2).
- OPKO Health peak revenue was $1.8B in 2021.
- OPKO Health annual revenue for 2023 was 863.5M, -14.01% growth from 2022.
- OPKO Health annual revenue for 2024 was 713.1M, -17.41% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
OPKO Health historical revenue
OPKO Health's peak revenue was $1.8B in 2021. The peak quarterly revenue was $182.2M in 2024(q2).
OPKO Health's revenue increased from $562.0k in 2002 to $713.1M currently. That's a 126,793.59% change in annual revenue.
OPKO Health annual revenue
OPKO Health annual revenue over time
| Fiscal year / year | OPKO Health revenue |
|---|---|
| 2009 | $4.4M |
| 2010 | $28.5M |
| 2011 | $28.0M |
| 2012 | $47.0M |
| 2013 | $96.5M |
| 2014 | $91.1M |
| 2015 | $491.7M |
| 2016 | $1.1B |
| 2017 | $966.0M |
| 2018 | $990.3M |
| 2019 | $901.9M |
| 2020 | $1.4B |
| 2021 | $1.8B |
| 2022 | $1.0B |
| 2023 | $863.5M |
| 2024 | $713.1M |
Rate OPKO Health's financial transparency
OPKO Health annual growth
OPKO Health saw the greatest revenue growth in 2007, when revenue increased by 6,415.38%.
OPKO Health had the lowest revenue growth in 2003, when revenue changed by -97.69%.
OPKO Health annual growth rate over time
| Year | OPKO Health growth |
|---|---|
| 2009 | -53%↓ |
| 2010 | 545%↑ |
| 2011 | -2%↓ |
| 2012 | 68%↑ |
| 2013 | 105%↑ |
| 2014 | -6%↓ |
| 2015 | 440%↑ |
| 2016 | 127%↑ |
| 2017 | -14%↓ |
| 2018 | 3%↑ |
| 2019 | -9%↓ |
| 2020 | 59%↑ |
| 2021 | 24%↑ |
| 2022 | -43%↓ |
| 2023 | -14%↓ |
| 2024 | -17%↓ |
OPKO Health jobs nearby
Do you work at OPKO Health?
Did OPKO Health meet its revenue projections?
OPKO Health financial information
| CEO | Phillip Frost |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 6,096 |
| Date Founded | 1991 |
| Headquarters | Miami, Florida |
| Number of Locations | 2 |
| Revenue | $713.1M |
| Net Income | -$328,405,000 |
| Gross Proft | $218.5M (2024) |
| EBITDA | $111.3M (2024) |
| PE Ratio | -39.55 |
| Tax Rate | -4.1% |
| Market Capitalization | $2.1B |
| Total Assets | $2,167,259,000 |
| Ticker | OPK |
OPKO Health jobs you might like
OPKO Health financing
OPKO Health received early financing of $31.0M on 2009-06-03.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $31M | 06/2009 |
| Post Ipo Debt | $175M | 02/2013 |
OPKO Health competitors
OPKO Health's top competitor, Seagen, earned an annual revenue of $2.0B.
OPKO Health's smallest competitor is InMed Pharmaceuticals with revenue of $1.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Novavax | $76,541 | $682.2M | 791 | 1 |
| Adverum Biotechnologies | $90,460 | $3.6M | 188 | 2 |
| MabVax Therapeutics | $49,255 | $1.6M | 11 | - |
| Aerie Pharmaceuticals | $45,136 | $194.1M | 353 | - |
| InMed Pharmaceuticals | $52,088 | $1.6M | 20 | - |
| BioReference Laboratories | $33,727 | - | 5,000 | - |
| Morphotek | $51,282 | $4.8M | 1 | - |
| Seagen | $85,008 | $2.0B | 900 | - |
| NanoString Technologies | $83,250 | $127.3M | 270 | - |
| Dynavax Technologies | $74,118 | $277.2M | 311 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
OPKO Health highest paying jobs
Zippia gives an in-depth look into the details of OPKO Health, including salaries, political affiliations, employee data, and more, in order to inform job seekers about OPKO Health. The employee data is based on information from people who have self-reported their past or current employments at OPKO Health. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by OPKO Health. The data presented on this page does not represent the view of OPKO Health and its employees or that of Zippia.
OPKO Health may also be known as or be related to OPKO HEALTH INC., OPKO Health, OPKO Health Inc, OPKO Health, Inc., Opko Diagnostics, LLC, Opko Health Inc and Opko Health, Inc.